Compass Therapeutics CEO Thomas Schuetz's 2021 pay jumps 106% to $5.3M
Compass Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
Compass Therapeutics reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, three executives at Compass Therapeutics received on average a compensation package of $3.8M, a 49% increase compared to previous year.
Average pay of disclosed executives at Compass Therapeutics
Thomas J. Schuetz, Chief Executive Officer, received $5.3M in total, which increased by 106% compared to 2020. 48% of Schuetz's compensation, or $2.5M, was in option awards. Schuetz also received $450K in bonus, $4K in salary, as well as $2.3M in stock awards.
Vered Bisker-Leib, Chief Operating Officer, received a compensation package of $4.5M, which increased by 73% compared to previous year. 52% of the compensation package, or $2.3M, was in stock awards.
Susan Kalled, Chief Scientific Officer, earned $1.8M in 2021.
Related executives
You may also like
Source: SEC filing on April 28, 2022.